Literature DB >> 29735117

Pediatric Ataxia: Focus on Chronic Disorders.

David R Lynch1, Ashley McCormick2, Kimberly Schadt3, Elizabeth Kichula3.   

Abstract

Evaluation of a pediatric patient presenting with ataxia can be expensive and time consuming. Acute causes tend to have a clear developmental paradigm, but chronic presentations are more likely to be secondary to a genetic disorder, either one that primarily causes ataxia or that presents ataxia as one of a multitude of symptoms. Evaluation should focus on a quick diagnosis for those that have treatment options and for those that require other systemic monitoring. Friedreich ataxia is the most common, and genetic testing can easily confirm the suspicion. Testing for vitamin E (for ataxia with isolated vitamin E deficiency) and alpha fetoprotein (for Ataxia Telangiectasia or AT) are important, as is empiric treatment with coenzyme Q10 for those genetic abnormalities that can lead to coenzyme Q deficiency. Clear family history, disease progression, physical examination focusing on type of ataxia and other associated neurologic features, and investigation of systemic involvement can help in focusing clinical assessment.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29735117     DOI: 10.1016/j.spen.2018.01.001

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  3 in total

1.  The National Italian Guidelines on the diagnosis and treatment of children with pediatric ataxias.

Authors:  Eleonora Lacorte; Paola Piscopo; Luciano Sagliocca; Luca Vignatelli; Domenica Taruscio; Nicola Vanacore
Journal:  Front Neurol       Date:  2022-10-04       Impact factor: 4.086

Review 2.  Movement Disorders in Genetic Pediatric Ataxias.

Authors:  Simone Gana; Enza Maria Valente
Journal:  Mov Disord Clin Pract       Date:  2020-04-06

3.  Iron Hack - A symposium/hackathon focused on porphyrias, Friedreich's ataxia, and other rare iron-related diseases.

Authors:  Gloria C Ferreira; Jenna Oberstaller; Renée Fonseca; Thomas E Keller; Swamy Rakesh Adapa; Justin Gibbons; Chengqi Wang; Xiaoming Liu; Chang Li; Minh Pham; Guy W Dayhoff Ii; Ben Busby; Rays H Y Jiang; Linh M Duong; Luis Tañón Reyes; Luciano Enrique Laratelli; Douglas Franz; Segun Fatumo; Atm Golam Bari; Audrey Freischel; Lindsey Fiedler; Omkar Dokur; Krishna Sharma; Deborah Cragun
Journal:  F1000Res       Date:  2019-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.